Business Card for James Shaw:


Lead, Patient-Reported Outcomes Assessment ...
 New York, NY area
Email Avail: 3 Day Free Trial


345 Park Ave
New York, NY 10154
Tel: (212) 546-4000

Last updated on 2018-01-18

About James Shaw:

James Shaw works as an Lead, Patient-Reported Outcomes Assessment ... for Bristol-Myers Squibb at New York, NY. The company's webpage is http://www.bms.com. For email, phone number and executive profiles for Lead, Patient-Reported Outcomes Assessment ... and other executives of Bristol-Myers Squibb at New York, NY, check Bristol-Myers Squibb at Joesdata.com. Not the James Shaw you are looking for? Do a quick search in our website and find other people named James Shaw.
James Shaw's Work History:
No information available..

James Shaw's Education:
No information available..

James Shaw's Co-workers:
As of January 24, 2020, James Shaw has 1438 co-workers under the company name Bristol-Myers Squibb at Joesdata.com.

About Bristol-Myers Squibb:


Warning: mysqli_fetch_assoc() expects parameter 1 to be mysqli_result, boolean given in /home2/joesdata/public_html/login/executivedetails.php on line 392
Bristol-Myers Squibb is located at 345 Park Ave , New York, NY 10154. It has over 10K employees. Its revenue is over $1B.

Company News:
2018-09-12 17:31:09
Bristol-Myers Squibb Announces Dividend
2018-09-06 18:54:14
Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference
2018-09-06 17:48:56
Bristol-Myers Squibb to Announce Results for Third Quarter 2018 on October 25
2018-09-06 17:30:46
Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference
2018-09-06 17:30:37
Bristol-Myers Squibb to Announce Results for Third Quarter 2018 on October 25
2018-09-05 18:07:03
Bristol-Myers Squibb Kicks Off Coast 2 Coast 4 Cancer Ride to Fundraise for the V Foundation for Cancer Research
2018-09-05 17:30:30
Bristol-Myers Squibb Kicks Off Coast 2 Coast 4 Cancer Ride to Fundraise for the V Foundation for Cancer Research
2018-08-30 19:18:40
U.S. Food and Drug Administration Accepts Bristol-Myers Squibbs Application for Sprycel (dasatinib) in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
2018-08-30 17:30:50
U.S. Food and Drug Administration Accepts Bristol-Myers Squibbs Application for Sprycel (dasatinib) in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
2018-08-28 17:31:03
Bristol-Myers Squibb Appoints Christopher Boerner Executive Vice President and Chief Commercial Officer

People in the same industry: